Transaction Details

Footnotes

The options were exercised and the shares were sold in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, on March 19, 2025. | The Common Shares reported herein as being sold were sold at a range of between $290.00 and $290.31 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. | The Common Shares reported herein as being sold were sold at a range of between $290.00 and $290.36 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range. | Common Shares being withheld in order to pay tax liability. | Options vested as follows: 1/3 on February 25, 2017, 1/3 on February 25, 2018 and 1/3 on February 25, 2019. | Total includes previously reported options from other tranches with different exercise prices, vesting and expiration dates.